Piper Jaffray Downgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Neutral

January 4, 2013 7:28 AM EST Send to a Friend
Get Alerts ENDP Hot Sheet
Price: $69.57 --0%

Rating Summary:
    15 Buy, 11 Hold, 4 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 9 | Down: 18 | New: 16
Trade ENDP Now!
Join SI Premium – FREE
Piper Jaffray downgraded Endo Pharmaceuticals Holdings Inc (NASDAQ: ENDP) from Overweight to Neutral with a price target of $28.00 (from $37.00).

For an analyst ratings summary and ratings history on Endo Pharmaceuticals Holdings Inc click here. For more ratings news on Endo Pharmaceuticals Holdings Inc click here.

Shares of Endo Pharmaceuticals Holdings Inc closed at $26.25 yesterday.




You May Also Be Interested In


Related Categories

Analyst PT Change, Downgrades

Related Entities

Piper Jaffray

Add Your Comment